Free Trial
NASDAQ:MTEX

Mannatech Q2 2023 Earnings Report

Mannatech logo
$8.15 -0.35 (-4.11%)
Closing price 07/15/2025 03:56 PM Eastern
Extended Trading
$8.15 0.00 (-0.01%)
As of 07/15/2025 05:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mannatech EPS Results

Actual EPS
-$0.59
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Mannatech Revenue Results

Actual Revenue
$32.59 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Mannatech Announcement Details

Quarter
Q2 2023
Time
N/A
Conference Call Date
Monday, August 14, 2023
Conference Call Time
6:00AM ET

Upcoming Earnings

Mannatech's Q2 2025 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled on Wednesday, August 13, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Mannatech Earnings Headlines

[ATTENTION] This Crypto Rocket Is About Launch…
Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to two crypto experts, that moment is here. Their Crypto Code Workshop shows how to get positioned before altcoins take off, ride the wave, and lock in gains — with a free $10 Bitcoin bonus just for attending.
Mannatech appoints Peter Griscom COO
See More Mannatech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Mannatech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mannatech and other key companies, straight to your email.

About Mannatech

Mannatech (NASDAQ:MTEX), Inc. is a global nutrition company specializing in the development, manufacture and marketing of dietary supplements and personal care products through a direct selling business model. Since its founding in 1993 in Texas, the company has focused on research-backed formulations centered on glyconutrient technology—complex carbohydrates believed to support cellular communication. Its flagship supplement, Ambrotose®, is designed to promote gastrointestinal health and overall wellness.

In addition to its core nutritional offerings, Mannatech’s product portfolio includes skin and body care lines formulated with proprietary botanical extracts and peptides. The Cerule line targets anti-aging and hydration, while the AgeLOC™ series integrates science-driven approaches to support skin resilience and youthfulness. Mannatech also offers targeted products for immune support, weight management and fitness recovery, enabling the company to address a broad spectrum of consumer health needs.

Mannatech distributes its products through a network of independent associates across North America, Europe, Asia, Latin America and the Middle East. This direct selling approach is supplemented by e-commerce platforms, allowing the company to tailor its distribution strategies to regional preferences and regulations. Over the years, Mannatech has expanded its manufacturing capabilities and established partnerships with third-party laboratories to ensure product quality and compliance with international standards.

Leadership at Mannatech emphasizes scientific research and global expansion. Kevin Guest, who was appointed Chief Executive Officer in 2021, brings extensive experience in consumer products and international operations. The executive team collaborates with a scientific advisory board to guide product innovation and clinical validation efforts. Headquartered in Flower Mound, Texas, Mannatech continues to invest in research initiatives and strategic partnerships to drive long-term growth and deliver health and wellness solutions to customers around the world.

View Mannatech Profile

More Earnings Resources from MarketBeat